Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Anabolics in osteoporosis: the emerging therapeutic tool.

Trivedi R, Mithal A, Chattopadhyay N.

Curr Mol Med. 2010 Feb;10(1):14-28. Review.

PMID:
20205677
2.

Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.

Brixen KT, Christensen PM, Ejersted C, Langdahl BL.

Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):260-70. Review.

3.

Anabolic skeletal therapy for osteoporosis.

Girotra M, Rubin MR, Bilezikian JP.

Arq Bras Endocrinol Metabol. 2006 Aug;50(4):745-54. Review.

4.

Investigational anabolic therapies for osteoporosis.

Trivedi R, Goswami R, Chattopadhyay N.

Expert Opin Investig Drugs. 2010 Aug;19(8):995-1005. doi: 10.1517/13543784.2010.501077. Review.

PMID:
20629616
5.

Anabolic Agents for Osteoporosis : What is Their Likely Place in Therapy?

Girotra M, Rubin MR, Bilezikian JP.

Treat Endocrinol. 2006;5(6):347-58.

PMID:
17107220
6.

Strontium ranelate in osteoporosis.

Reginster JY.

Curr Pharm Des. 2002;8(21):1907-16. Review.

PMID:
12171530
7.

[Strontium ranelate: a novel concept for the treatment of osteoporosis].

Dimai HP.

Wien Klin Wochenschr. 2005 Nov;117(21-22):728-38. Review. German.

PMID:
16416353
8.

[Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].

Uebelhart D, Frey D, Frey-Rindova P, Goerres G, Michel BA.

Z Rheumatol. 2003 Dec;62(6):512-7. Review. German.

PMID:
14685711
9.

[Anabolic treatment for osteoporosis: PTH treatment].

Kaji H, Sugimoto T.

Clin Calcium. 2006 Sep;16(9):1480-85. Review. Japanese.

PMID:
16951472
10.

Drug combination strategies for osteoporosis.

Audran M.

Joint Bone Spine. 2006 Jul;73(4):374-8. Epub 2006 May 6. Review.

PMID:
16765628
11.

Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.

Neuprez A, Hiligsmann M, Scholtissen S, Bruyere O, Reginster JY.

Adv Ther. 2008 Dec;25(12):1235-56. doi: 10.1007/s12325-008-0125-8. Review.

PMID:
19066755
12.

Treatment of osteoporosis with parathyroid hormone and teriparatide.

Pleiner-Duxneuner J, Zwettler E, Paschalis E, Roschger P, Nell-Duxneuner V, Klaushofer K.

Calcif Tissue Int. 2009 Mar;84(3):159-70. doi: 10.1007/s00223-009-9218-x. Epub 2009 Feb 3. Review. Erratum in: Calcif Tissue Int. 2009 Nov;85(5):463.

PMID:
19189037
13.

The potential of parathyroid hormone as a therapy for osteoporosis.

Rubin MR, Bilezikian JP.

Int J Fertil Womens Med. 2002 May-Jun;47(3):103-15. Review.

PMID:
12081255
14.

Strontium as therapy for osteoporosis.

Marie PJ.

Curr Opin Pharmacol. 2005 Dec;5(6):633-6. Epub 2005 Sep 23. Review.

PMID:
16183330
15.

PTH (1-34): a novel anabolic drug for the treatment of osteoporosis.

Holick MF.

South Med J. 2005 Nov;98(11):1114-7. Review.

PMID:
16353381
16.

Emerging anabolic treatments in osteoporosis.

Mosekilde L, Tørring O, Rejnmark L.

Curr Drug Saf. 2011 Apr;6(2):62-74. Review.

PMID:
21524248
17.

Parathyroid hormone as an anabolic therapy for women and men.

Bilezikian JP, Rubin MR, Finkelstein JS.

J Endocrinol Invest. 2005;28(8 Suppl):41-9. Review.

PMID:
16329201
18.

The cellular and clinical parameters of anabolic therapy for osteoporosis.

Rosen CJ.

Crit Rev Eukaryot Gene Expr. 2003;13(1):25-38. Review.

PMID:
12839095
19.
20.

Anabolic agents for treating postmenopausal osteoporosis.

Meunier PJ.

Joint Bone Spine. 2001 Dec;68(6):576-81. Review.

PMID:
11809001

Supplemental Content

Support Center